Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.

被引：0
|
作者：
Nakagami, Y. [1 ]
Kano, D. [1 ]
Kusumoto, M. [1 ]
机构：
[1] Natl Canc Ctr, Chiba, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P747
引用
收藏
页码：S698 / S699
页数：2
相关论文
共 50 条
  • [11] Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
    Takalkar, Amol
    Paryani, Bhavna
    Skweres, Justin
    Adams, Scott
    Devarakonda, Srinivas
    Dhawan, Manish
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [12] NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases
    Umeweni, Nwamaka
    Knight, Helen
    McVeigh, Gary
    LANCET ONCOLOGY, 2016, 17 (03): : 275 - 276
  • [13] MICRODISTRIBUTION OF ALPHA PARTICLE EMITTING RADIUM-223 DICHLORIDE IN MODELS OF PROSTATE CANCER BONE METASTASIS
    Abou, Diane
    Ulmert, David
    Hobbs, Robert
    Riddle, Ryan
    Thorek, Daniel
    JOURNAL OF UROLOGY, 2015, 193 (04): : E551 - E551
  • [14] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [15] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Uemura, Hiroji
    Uemura, Hirotsugu
    Matsubara, Nobuaki
    Kinuya, Seigo
    Hosono, Makoto
    Yajima, Yoko
    Doi, Toshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (05) : 954 - 963
  • [16] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
  • [17] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Hiroji Uemura
    Hirotsugu Uemura
    Nobuaki Matsubara
    Seigo Kinuya
    Makoto Hosono
    Yoko Yajima
    Toshihiko Doi
    International Journal of Clinical Oncology, 2017, 22 : 954 - 963
  • [18] Efficacy and tolerance of radium-223 dichloride in patients treated for castration-resistant prostate cancer with bone metastases
    Awoudou, C.
    Bathily, E. H. A. L.
    Djigo, M. S.
    Ndong, B.
    Mbodj, M.
    Paulus, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (03): : 150 - 157
  • [19] Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer
    Nakajima, Kenichi
    Edenbrandt, Lars
    Mizokami, Atsushi
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (09) : 668 - 673
  • [20] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
    Curley, Tracy
    Arauz, Gabrielle
    Jensen, Trine
    Wahba, Mona
    Delacruz, Anthony
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
12345